Convergence Investment Partners, LLC Atri Cure, Inc. Transaction History

Convergence Investment Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 23, 2019	SELL	$26.85 - $30.74 $271,211 - $310,504	-10,101 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$26.38 - $33.34 $154,534 - $195,305	-5,858 Reduced 36.71%	10,101 $271,000
Q4 2018 Feb 13, 2019	BUY	$26.66 - $34.85 $425,466 - $556,171	15,959 New	15,959 $488,000

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.62B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.